These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21904406)
1. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST]. Gutierrez MR; Dorronsoro ML; Marco AM; Pérez IR; Villegas IA; Virseda JM An Sist Sanit Navar; 2011; 34(2):245-51. PubMed ID: 21904406 [TBL] [Abstract][Full Text] [Related]
2. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018 [TBL] [Abstract][Full Text] [Related]
3. DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach. Wada T; Tanabe S; Ishido K; Higuchi K; Sasaki T; Katada C; Azuma M; Naruke A; Kim M; Koizumi W; Mikami T World J Gastroenterol; 2013 Dec; 19(47):9133-6. PubMed ID: 24379641 [TBL] [Abstract][Full Text] [Related]
4. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
5. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors. Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B; Hornick JL; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564 [TBL] [Abstract][Full Text] [Related]
7. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619 [TBL] [Abstract][Full Text] [Related]
8. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1. Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821 [TBL] [Abstract][Full Text] [Related]
9. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036 [TBL] [Abstract][Full Text] [Related]
10. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340 [TBL] [Abstract][Full Text] [Related]
11. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166 [TBL] [Abstract][Full Text] [Related]
12. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors. Jang BG; Lee HE; Kim WH Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012 [TBL] [Abstract][Full Text] [Related]
13. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology. Sui XL; Wang H; Sun XW Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337 [TBL] [Abstract][Full Text] [Related]
14. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor? Swalchick W; Shamekh R; Bui MM Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours. Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765 [TBL] [Abstract][Full Text] [Related]
16. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors. Abdel-Hadi M; Bessa SS; Hamam SM J Egypt Natl Canc Inst; 2009 Sep; 21(3):237-47. PubMed ID: 21132034 [TBL] [Abstract][Full Text] [Related]
18. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035 [TBL] [Abstract][Full Text] [Related]
20. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Lee CH; Liang CW; Espinosa I Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]